Ginkgo Bioworks (DNA) Reports In-Line Q1 EPS, misses on revenue

Ginkgo Bioworks (NYSE: DNA) reported Q1 EPS of ($0.08), in-line with the analyst estimate of ($0.08). Revenue for the quarter came in at $37.94 million versus the consensus estimate of $46.37 million.

For earnings history and earnings-related data on Ginkgo Bioworks (DNA) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Cuprina to buy seven-clinic Singapore healthcare group for S$4M
• Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation